1. Home
  2. RIGL vs MEC Comparison

RIGL vs MEC Comparison

Compare RIGL & MEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RIGL
  • MEC
  • Stock Information
  • Founded
  • RIGL 1996
  • MEC 1945
  • Country
  • RIGL United States
  • MEC United States
  • Employees
  • RIGL N/A
  • MEC N/A
  • Industry
  • RIGL Biotechnology: Pharmaceutical Preparations
  • MEC Industrial Specialties
  • Sector
  • RIGL Health Care
  • MEC Industrials
  • Exchange
  • RIGL Nasdaq
  • MEC Nasdaq
  • Market Cap
  • RIGL 335.5M
  • MEC 329.4M
  • IPO Year
  • RIGL 2000
  • MEC 2019
  • Fundamental
  • Price
  • RIGL $38.85
  • MEC $14.60
  • Analyst Decision
  • RIGL Buy
  • MEC Strong Buy
  • Analyst Count
  • RIGL 5
  • MEC 3
  • Target Price
  • RIGL $38.20
  • MEC $21.33
  • AVG Volume (30 Days)
  • RIGL 995.6K
  • MEC 161.8K
  • Earning Date
  • RIGL 08-05-2025
  • MEC 08-05-2025
  • Dividend Yield
  • RIGL N/A
  • MEC N/A
  • EPS Growth
  • RIGL N/A
  • MEC 64.18
  • EPS
  • RIGL 5.43
  • MEC 0.86
  • Revenue
  • RIGL $267,921,000.00
  • MEC $524,606,000.00
  • Revenue This Year
  • RIGL $59.93
  • MEC N/A
  • Revenue Next Year
  • RIGL N/A
  • MEC $17.38
  • P/E Ratio
  • RIGL $7.15
  • MEC $17.07
  • Revenue Growth
  • RIGL 105.62
  • MEC N/A
  • 52 Week Low
  • RIGL $12.66
  • MEC $11.72
  • 52 Week High
  • RIGL $43.72
  • MEC $23.02
  • Technical
  • Relative Strength Index (RSI)
  • RIGL 68.57
  • MEC 46.47
  • Support Level
  • RIGL $39.00
  • MEC $14.22
  • Resistance Level
  • RIGL $42.08
  • MEC $14.80
  • Average True Range (ATR)
  • RIGL 2.32
  • MEC 0.50
  • MACD
  • RIGL -0.37
  • MEC 0.07
  • Stochastic Oscillator
  • RIGL 53.26
  • MEC 57.65

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

About MEC Mayville Engineering Company Inc.

Mayville Engineering Co Inc is involved in a manufacturing partner providing a full suite of manufacturing solutions from concept to production, including design, prototyping and tooling, fabrication, aluminum extrusion, coating, assembly and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, power sports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly and logistic services.

Share on Social Networks: